menu
The microbial contract biomanufacturing market is projected grow at an annualized rate of 8.7%, till 2030- Rootsanalysis
The microbial contract biomanufacturing market is projected grow at an annualized rate of 8.7%, till 2030- Rootsanalysis
Roots Analysis has done a detailedstudy on “MicrobialContract Biomanufacturing Market, 2020-2030” covering key aspects of the industry and identifyingpotential future growth opportunities.

Roots Analysis has done a detailedstudy on MicrobialContract Biomanufacturing Market, 2020-2030covering key aspects of the industry and identifyingpotential future growth opportunities.

 

To order this 320+ page report, which features 150+ figuresand 150+ tables, please visit this - https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html

 

Key Market Insights

§ Over 115 companies, across the world, claim to offer avariety of product development, manufacturing and support services, for varioustypes of biologics that are manufactured / expressed in microbial systems

§ Majority of the players have the necessary infrastructure /capability to produce different biologics, primarily proteins, at all scalesusing bacterial / yeast expression vectors

§ The market features the presence of severalwell-established players across the globe; the US, the UK and Germany emergedas current hubs for production of biologics using microbial strains

§ Several service providers, involved in this domain, aresteadily expanding their capabilities in order to enhance their respectiveservice portfolio and maintain a competitive edge in the industry

§ The growth trend of outsourcing microbial manufacturingoperations is evident from the rise in recent partnership activity, as well asexpansion initiatives undertaken by CMOs to meet the growing demand for novelbiologics

§ Big pharma players have also made significant investmentsin this domain through establishment of new facilities, entering into strategiccollaborations and undertaking financial investments

§ Future growth of the market is likely to be driven byincreased adoption of novel biologics that are produced via microbial systems;we expect the service-based revenues to grow at a CAGR of over 8%

§ In the long term, the projected opportunity for contractbiomanufacturing is anticipated to be distributed across contract serviceproviders of different sizes, scales of manufacturing and key geographicalregions

 

For more information, please visit https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html

 

Table of Contents

 

1.         PREFACE

1.1.       Scopeof the Report

1.2.       ResearchMethodology

1.3.       Chapter Outlines